Search
01/03/2023
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
Nunez, Y, Garcia-Leon, A, Falgas, A, Serna, N, Sanchez-Garcia, L, Garrido, A, Sierra, J, Gallardo, A, Unzueta, U, Vazquez, E, Villaverde, A, Mangues, R, Casanova, I. T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics. 2023; 15(3)DOI:10.3390/pharmaceutics15030727. PMID:36986589. IF:4.900(Q1/2D).
01/03/2023
Quantitative PCR for the Diagnosis of HCMV Pneumonia in HSCT Recipients and Other Immunocompromised Hosts
Berengua, C, Martino, R. Quantitative PCR for the Diagnosis of HCMV Pneumonia in HSCT Recipients and Other Immunocompromised Hosts. Hemato. 2023; 4(1)DOI:10.3390/hemato4010008. PMID:. IF:(Q/D).
01/03/2023
Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy
Castillo-Regalado E., Ríos R., Aràjol C., Gely C., Márquez L., Calafat M., González-Muñoza C., Cañete F., Mesonero F., Guardiola J., Garcia-Planella E., Mañosa M., Domènech E.. Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy. Gastroenterologia y Hepatologia. 2023; 46(3)DOI:10.1016/j.gastrohep.2022.09.003. PMID:36179946. IF:2.200(Q3/6D).
01/03/2023
Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society].
Pedro-Botet J, Barrios V, Sánchez-Margalet V, Tamargo J, Arrieta F, Gámez JM, Gimeno-Orna JA, Escobar C, Gómez-Doblas JJ, Pérez A. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society].. Endocrinologia Diabetes y Nutricion. 2023; 70(Suppl.1)DOI:10.1016/j.endien.2022.11.009. PMID:36402735. IF:1.800(Q3/8D).
01/03/2023
Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
Sanmarti, R, Corominas, H. Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5)DOI:10.3390/jcm12051734. PMID:36902522. IF:3.000(Q1/2D).
01/03/2023
Perception of survival/laryngeal preservation trade-off in advanced T-stage laryngeal cancer
Laccourreye, O, Mirghani, H, Guiquerro, S, Quer, M, Giraud, P. Perception of survival/laryngeal preservation trade-off in advanced T-stage laryngeal cancer. European Annals of Otorhinolaryngology-Head and Neck Diseases. 2023; 140(2)DOI:10.1016/j.anorl.2022.12.008. PMID:36642664. IF:1.900(Q2/3D).
01/03/2023
GACETA SANITARIA in 2022. Maximum historical impact factor and suitability for continuous publication
Bermudez-Tamayo, C, Hernandez, MN, Alguacil, J, Cantarero, D, Portino, MC, Casino, G, Calvente, MG, Hernan, M, Garcia, LP, Cantero, MTR, Segura, A, Amez, JG, Juarez, L, Miranda, JJ, March, JC, Marcos-Marcos, J, Mar, J, Peiro, R, Alvarez-Dardet, C. GACETA SANITARIA in 2022. Maximum historical impact factor and suitability for continuous publication. Gaceta Sanitaria. 2023; 37DOI:10.1016/j.gaceta.2023.102295. PMID:36871443. IF:1.500(Q3/7D).
28/02/2023
Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia
Vargas-Poussou, R, Claverie-Martin, F, Prot-Bertoye, C, Carotti, V, van der Wijst, J, Perdomo-Ramirez, A, Fraga-Rodriguez, GM, Hureaux, M, Bos, C, Latta, F, Houillier, P, Hoenderop, JGJ, de Baaij, JHF. Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(3)DOI:10.1093/ndt/gfac182. PMID:35561741. IF:4.800(Q1/2D).